Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
Skeletal involvement in metastatic castrate-resistant prostate cancer (mCRPC) is common and results in significant morbidity and mortality. The interaction of prostate cancer with the bone microenvironment contributes to progression of cancer in the bone leading to skeletal-related events (SREs). St...
Main Authors: | Joelle El-Amm, Jeanny B. Aragon-Ching |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.4137/CMO.Ss30751 |
Similar Items
-
Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2016-03-01) -
Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
by: Joelle El-Amm, et al.
Published: (2013-01-01) -
The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer
by: Joelle El-Amm, et al.
Published: (2019-02-01) -
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
by: Joelle El-Amm, et al.
Published: (2013-08-01) -
Erratum for “Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide”
by: Joelle El-Amm, et al.
Published: (2013-01-01)